Berg Pharma a Division of Berg, LLC Information

Berg Pharma is no longer using this LinkedIn account please follow us on our new Berg company page at: https://www.linkedin.com/company/berghealth?trk=company_name Berg's Pharma division focuses our research on understanding how alterations in metabolism relate to disease onset. The company has a deep pipeline of early-stage technologies in CNS diseases and metabolic diseases that complement its late-stage clinical trial activity in cancer and prevention of chemotoxicity. Armed with use of the Interrogative Biology® discovery platform that translates biological output into viable therapeutics and a robust biomarker library, Berg Pharma is poised to realize its pursuit of a healthier tomorrow.